VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Vascular Endothelial Growth Factor A (VEGF-A) binding to VEGFR2 receptor tyrosine kinase initiates signaling pathways crucial for vascular development.
• Different VEGF-A isoforms can elicit distinct signal transduction and endothelial responses, but the mechanisms controlling these differences are not fully understood.
• Membrane trafficking of receptor-ligand complexes is increasingly recognized for its role in modulating signal transduction and protein turnover.

Purpose of the Study:

• To investigate how distinct VEGF-A isoforms (VEGF-A165, VEGF-A121, VEGF-A145) influence VEGFR2 endocytosis and subsequent signal transduction.
• To elucidate the role of isoform-specific receptor trafficking in controlling cellular responses related to vascular development.

Main Methods:

• Utilized various VEGF-A isoforms (VEGF-A165, VEGF-A121, VEGF-A145) to study VEGFR2 endocytosis and trafficking patterns.
• Investigated the impact of disrupting clathrin-dependent endocytosis on VEGFR2 activation and signaling.
• Analyzed VEGFR2 ubiquitylation, proteolysis, and degradation in response to different VEGF-A isoforms.

Main Results:

• Demonstrated that distinct VEGF-A isoforms promote unique patterns of VEGFR2 endocytosis and delivery to early endosomes.
• Showed that differential VEGFR2 trafficking is directly linked to VEGF-A isoform-specific signal transduction events.
• Found that disruption of clathrin-dependent endocytosis inhibits VEGF-A isoform-specific VEGFR2 activation, signaling, and leads to depletion of membrane-bound VEGFR1 and VEGFR2.

Conclusions:

• Different VEGF-A isoforms induce distinct VEGFR2 endocytic trafficking pathways.
• VEGF-A isoform-mediated VEGFR2 trafficking regulates specific signal transduction events, protein turnover, and degradation.
• This study provides novel insights into how diverse cellular outcomes are achieved through isoform-specific interactions between VEGF-A and VEGFR2.